News Daily News El Análisis mediante OCT Revela un Patrón de Cobertura SLF Tardía en OTC October 17, 2014
News Features Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation Todd Neale October 10, 2014
News Conference News TCT 2014 Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation Todd Neale October 10, 2014
News Daily News Stroke, Systemic Embolism Risk Higher When Amiodarone Combined with Warfarin Rather Than Apixaban L.A. McKeown October 10, 2014
News Daily News El Riesgo de Sufrir ACV y Embolismos Sistémicos es Más Alto cuando Combinamos Amiodarona + Warfarina que Amiodarona +Apixaban L.A. McKeown October 10, 2014
News Daily News Subestudio del HORIZONS-AMI: Las Mujeres Corren Más Riego Hemorrágico Post-STEMI Yael L. Maxwell October 03, 2014
News Daily News Subanálisis del PLATO: Las Hemorragias Graves se asocian a una Mayor Mortalidad a Corto Plazo en el Manejo de los SCA Yael L. Maxwell October 03, 2014
News Daily News PLATO Subanalysis: Major Bleeding Linked With Increased Short-term Mortality in ACS Yael L. Maxwell October 03, 2014
News Daily News HORIZONS-AMI Substudy: Women at Higher Risk for Bleeding After STEMI Yael L. Maxwell October 03, 2014
News Industry News Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease September 17, 2014
News Conference News ESC 2014 ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI Patients Yael L. Maxwell September 03, 2014
News Daily News Low Trial Participation Rate of MI Patients Raises Questions of Applicability Todd Neale September 02, 2014
News Daily News El Bajo Índice de Participación del Ensayo de Pacientes IM Plantea Dudas de Aplicabilidad Todd Neale September 02, 2014
News Industry News Sanofi and Regeneron to Present Results from Four Phase 3 Alirocumab August 25, 2014
News Industry News Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia July 30, 2014